Cappella receives $17.3m in venture funding

Fountain Healthcare Partners, Mitsui & Co. Venture Partners and Enterprise Ireland have participated in a $17.3m (EUR12.5m) third round of funding for Galway-based medical device business Cappella, alongside existing backers PolyTechnos Venture-Partners and ACT Venture Capital.Founded in 2004, Cappella is developing devices – such as its Sidebranch stent – to address coronary artery lesions in sidebranch and bifurcation locations. The company was granted CE mark approval for its first device in Europe earlier this year.

SUBSCRIPTION REQUIRED

To view the deal details,  or subscribe.